BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 19862822)

  • 1. PDGFRA, KIT, and KDR Gene Amplification in Glioblastoma: Heterogeneity and Clinical Significance.
    Carlotto BS; Trevisan P; Provenzi VO; Soares FP; Rosa RFM; Varella-Garcia M; Zen PRG
    Neuromolecular Med; 2023 Sep; 25(3):441-450. PubMed ID: 37610648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic changes observed in a case of adult pilocytic astrocytoma revealed by array CGH analysis.
    Pećina-Šlaus N; Gotovac K; Kafka A; Tomas D; Borovečki F
    Mol Cytogenet; 2014; 7(1):95. PubMed ID: 25606054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed Analysis of Focal Chromosome Arm 1q and 6p Amplifications in Urothelial Carcinoma Reveals Complex Genomic Events on 1q, and SOX4 as a Possible Auxiliary Target on 6p.
    Eriksson P; Aine M; Sjödahl G; Staaf J; Lindgren D; Höglund M
    PLoS One; 2013; 8(6):e67222. PubMed ID: 23825644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers.
    Soltan MA; Eldeen MA; Eid RA; Alyamani NM; Alqahtani LS; Albogami S; Jafri I; Park MN; Alsharif G; Fayad E; Mohamed G; Osman R; Kim B; Zaki MSA
    Front Mol Biosci; 2023; 10():1017148. PubMed ID: 37033447
    [No Abstract]   [Full Text] [Related]  

  • 5. CHD1L: a novel oncogene.
    Cheng W; Su Y; Xu F
    Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.
    Chari R; Thu KL; Wilson IM; Lockwood WW; Lonergan KM; Coe BP; Malloff CA; Gazdar AF; Lam S; Garnis C; MacAulay CE; Alvarez CE; Lam WL
    Cancer Metastasis Rev; 2010 Mar; 29(1):73-93. PubMed ID: 20108112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone.
    Niini T; Lahti L; Michelacci F; Ninomiya S; Hattinger CM; Guled M; Böhling T; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2011 May; 50(5):291-306. PubMed ID: 21254299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.
    Wozniak A; Sciot R; Guillou L; Pauwels P; Wasag B; Stul M; Vermeesch JR; Vandenberghe P; Limon J; Debiec-Rychter M
    Genes Chromosomes Cancer; 2007 Mar; 46(3):261-76. PubMed ID: 17171690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN
    J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
    De Angelis PM; Clausen OP; Schjølberg A; Stokke T
    Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
    Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
    Niini T; López-Guerrero JA; Ninomiya S; Guled M; Hattinger CM; Michelacci F; Böhling T; Llombart-Bosch A; Picci P; Serra M; Knuutila S
    Genes Chromosomes Cancer; 2010 Feb; 49(2):132-43. PubMed ID: 19862822
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.